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VIRAL ETIOLOGY OF THE GUILLAIN-BARRÉ SYNDROME:
LOOKING FOR THE IDIOPATHIC ANSWER
ETIOLOGÍA VIRAL EN EL SÍNDROME DE GUILLAIN-BARRÉ: BUSCANDO UNA RESPUESTA A LO IDIOPÁTICO
Jorge Arturo Vega Fernández1,a , Danny Omar Suclupe Campos1,a , Mayra Massely Coico Vega1,a ,
Franklin Rómulo Aguilar Gamboa2,a

ABSTRACT
Guillain-Barré Syndrome (GBS) is a rare disorder of the nervous system, where the patient's immune system
attacks the peripheral nerve cells in the arms and legs, causing muscle weakness, loss of sensation and
sometimes total paralysis. The origin of this disorder has been associated with immune responses triggered by
post-infection with Campylobacter spp. However, when there is no obvious cause of the disease, it is usually not
investigated due to the greater interest in the treatment. Therefore, most cases are reported as idiopathic origin.
Between January and March 2016 worldwide, GBS outbreaks were reported in eight countries, linked to the
emergence of the Zika virus. In Peru, GBS outbreaks have been reported more frequently since the end of 2018
and, although no association with Zika has been con rmed, the increase in cases, the geographical extension
where they occurred and the clinical characteristics of aﬀected patients, have common patterns that lead to
suspect an infectious origin mainly of viral type. Therefore, it is important to know the current scienti c
evidence about the role that some viruses play in this syndrome, allowing us to expand our epidemiological
picture with new tools to deal with this disease.
Keywords: Guillain-Barre Syndrome; Viruses; Etiology. (Source : MeSH - NLM)

RESUMEN
El Síndrome de Guillain-Barré (SGB) es un raro trastorno del sistema nervioso, donde el sistema inmunológico
del paciente ataca las neuronas periféricas en extremidades, causando debilidad muscular, pérdida de
sensibilidad y a veces parálisis total. El origen de este trastorno, ha sido asociado a respuestas inmunes
desencadenadas luego de la infección por Campylobacter spp. Sin embargo, cuando no existe una causa
evidente de la enfermedad, esta no suele ser investigada debido al mayor interés que requiere el tratamiento.
Por ello, la mayoría de los casos se noti can como origen idiopático. Entre Enero y Marzo de 2016 a nivel
mundial se registraron brotes del SGB en ocho países, vinculados con la emergencia del virus Zika. En Perú,
desde nales de 2018 se ha reportado con mayor frecuencia brotes de SGB y aunque no se ha con rmado
asociación con Zika, el incremento de casos, la extensión geográ ca donde se produjeron y las características
clínicas de los pacientes afectados, tienen patrones comunes que llevan a sospechar un origen infeccioso
principalmente de tipo viral. Por lo tanto, es importante conocer la evidencia cientí ca actual acerca del rol que
desempeñan algunos virus en este síndrome, permitiendo ampliar nuestro panorama epidemiológico con
nuevas herramientas para hacer frente a esta enfermedad.
Palabras clave: Síndrome de Guillain-Barré; Virus; Etiología. (Fuente: DeCS BIREME)
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INTRODUCTION
Guillain-Barré Syndrome (GBS) is de ned as an acute

given the increase in cases recorded in recent years in

polyradiculoneuropathy, characterized by a accid,

the Region of the Americas. Likewise, clinical laboratory

ascending, and symmetric paralysis of the limbs, rapidly

tools are described that allow their adequate

progressive with hypore exia or are exia, which may

investigation and interpretation, since this is usually a

be associated with sensory disturbances and cranial

frequent obstacle that motivates the under-reporting

nerve de cits in some patients. It occurs more

of microorganisms, mainly viruses, as part of the

frequently in young adults, with men being more

probable etiology of this syndrome.

aﬀected than women (3:2 ratio)

(1,2)

. With the

advancement of medical research, the term GBS began

METHODOLOGY

to be applied to a broad spectrum of acquired acute

In this article, everything related to GBS and its viral

in ammatory polyradiculoneuropathies,

etiology has been reviewed, using the MEDLINE

immunologically mediated and presumably triggered

accessed from PubMed, Web of Science, Scopus, Scielo,

by a previous infection (post-infectious), with various

Virtual Health Library (VHL). The search was performed

pathophysiological mechanisms (demyelination,

in isolation or a combination of these keywords

motor or sensory axonal injury -motor)(3,4).

"Guillain-Barré syndrome" and its combinations with
"virus/etiology". Original articles, reviews, case reports

Between January and March 2016, GBS outbreaks were
reported worldwide in eight countries (1) , linked to the
emergence of Zika virus as a concomitant infection in
many cases reported in the Region of the Americas (5).
Likewise, at the end of the summer of 2018 and autumn
of 2019, the north and center of Peru had reported a
disproportionate increase in GBS cases, and due to the
geographical extension where they occurred and the
clinical characteristics of the aﬀected patients, etiology
was suggested. viral, with Zika and Enterovirus D68
being the main suspects(6). However, a large number of
cases do not identify the infectious agents and are more
likely to end up for epidemiological registry purposes as
cases of idiopathic origin.

or case series, and information obtained from web
pages that develop the central theme of the article were
identi ed.

PATHOPHYSIOLOGY OF GBS
Diﬀerent variants or subtypes of GBS have been
described according to their clinical and
neurophysiological characteristics, including acute
in ammatory demyelinating polyneuropathy (AIDP),
acute motor axonal neuropathy (AAM), acute sensorymotor axonal neuropathy (NASMA), and Miller-Fisher
Syndrome (MFS)(3). The diﬀerent subtypes are mediated
by immune mechanisms that involve autoantibodies
causing structural and functional damage mainly to the

It is necessary to broaden our epidemiological

myelin and axons of the peripheral nervous system

panorama considering other probable etiological

(PNS) (4,7). The immunopathogenesis diﬀers in each of

agents such as viruses, which are also widely

them; however, those involving cells and antibodies

recognized in the scienti c literature but whose

against myelin constituents of the PNS (PDIA) can be

participation is usually little studied and dismissed,

grouped together; and to subtypes of fundamentally

either due to lack of resources, complexity in their

axonal commitment (NAMA, NASMA and SMF) (Figure

diﬃcult y of detec tion, or simply due to the

1)(3,8). Although both elements of the immune response

interpretation of serological and molecular tests.

(T and B lymphocytes) play an important role, current
understanding holds that GBS is mediated by

This article brings together current information on the

antibodies that damage the myelin membrane and

recognized and probable associations between viral

axons of the PNS, due to cross-reactivity with bacterial

infections and GBS that should be taken into account

epitopes and/or viral by molecular mimicry (9,10).
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Figure 1. Main subtypes of GBS. Antibody-mediated injury to PNS neurons classi es GBS
subtypes into two groups. Those that damage the myelin membrane and those that damage
the axonal membrane with consequent conduction failure. Modi ed from Guillain-Barré
Syndrome (Willison, Jacobs & van Doorn, Lancet. 2016;388(10045):717-727)(11)
The most common form of GBS is PDIA, which arises
from demyelination of the peripheral nerve, mediated
by antibodies, macrophages, and complement
deposition in the myelin membranes of Schwann cells
(Figure 2). The demyelination process is generalized and
aﬀects most of the myelinated limbs, and lower axial
cranial motor and sensory nerves, but curiously it does
not aﬀect myelinating axons that innervate extraocular
muscles that are aﬀected in FMS (11).
In contrast to PDIA, the main target for attack by the
immune system in the NAMA and NASMA variants is the
axolemmal membrane. This in ammatory process
occurs predominantly in either the nerve roots or distal
nerve terminals. (Figure 1). The immune attack can lead
to conduction block by reversible axonal injury at best
or complete axonal transaction at worst. Wallerian
degeneration (disruption of the axon and its myelin
sheath after injury to the proximal part of the axon or

the neuronal soma) is a typical event in these variants of
GBS (11).
Gangliosides, carbohydrate residues linked to a lipid
fraction, are found forming a super cial part of cell
membranes in the peripheral nervous system (12,13).
Approximately 188 types have been characterized in
vertebrates (14) and they constitute speci c classic
molecular targets of antiganglioside antibodies (AGA)
present in this disease. Molecular mimicry between
infectious agents and gangliosides plays an important
role in the induction of these antibodies that contribute
to peripheral nerve in ammation-demyelination
processes in patients with GBS(15). Various studies show
that lipooligosaccharides (LOS) from infectious
organisms contain epitopes that are similar to
gangliosides in peripheral nerves, for example, in
Campylobacter jejuni, LOS mimics the membrane
gangliosides GM1, GM1b, GD1a, and GalNAc-GD1a very
well. and anti-LOS antibodies produced against
infection have cross-reactivity with antiganglioside
antibodies resulting in injury to peripheral nerve bers
Pág. 586
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In patients with FMS, oculomotor weakness has been

(Figure 2)(15).

associated with anti-GQ1b antibodies, where the
Similarly, in patients with NAMA, antibodies against C.

ganglioside GQ1b is the antigenic target in the nerves

jejuni and H. inﬂuenzae are cross-reactive with IgG

that innervate the extraocular muscles (Figure 2) (7,11).

immunoglobulin subclasses IgG1 and IgG3 that bind to
gangliosides, producing complement-dependent
axonal damage(15). In animal models, these axonal
injuries are due to complement

xation with

macrophage recruitment and attack complex
deposition (Figure 2)

Unlike NAMA, the immune cascade involved in PDIA is
less well understood for several reasons. First, a broader
range of immune stimulants causes PDIA, including
bacterial and viral infections, and post-vaccination
reactions. Second, the speci c antibody biomarkers

. This immunological cascade

have yet to be characterized. Alternatively, nerve-

disrupts the anatomical and physiological integrity of

speci c T cells, directed against yet unknown antigens,

the exposed membranes in the nerve terminals and

might play a more important role in PDIA than is

nodes of Ranvier, causing nerve conduction block.

currently known (Figure 2) (11).

(16)

Figure 2. Molecular mimicry between infectious agents and membrane gangliosides present in the nodes of
Ranvier, the myelin sheath in Schwann cells, or in the terminal nerves that innervate the oculomotor muscles, plays
an important role in the induction of antiganglioside antibodies. These, with complement activation, the
recruitment of circular macrophages, and the attack complex, produce membrane damage by myelin detachment
in PDIA or direct axonal damage in NAMA and Miller-Fisher syndrome. The pathological changes produce nerve
conduction failure and consequent muscle weakness. Modi ed from Guillain-Barré Syndrome: pathogenesis,
diagnosis, treatment and prognosis (van den Berg et al, Nat Rev Neurol. 2014;10(8):469‐482) (2)
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PROBABLE ROLE OF VIRUSES IN
C AU S I N G G U I L L A I N BA R R É
SYNDROME
Cytomegalovirus and antiganglioside antibodies
as evidence of the autoimmune factor in GBS.
Cytomegalovirus (CMV) infection is very common and
has a worldwide distribution. It occurs at any age, with a
higher incidence during the rst years of life. CMV is the
main cause of congenital viral infection, and it is
estimated that the infection is present in 0.5-1% of all

In cases that report an association between CMV and
GBS, both positive anti-CMV and anti-GM2 IgM (22) , some
studies even describe increases inanti-GM2 IgM, antiGalNAc-GD1a, and anti-GalNAc-GD1a antibodies.
myosin, a protein that exists in trace amounts at the
nodes of Ranvier. However, these are no longer
detectable four months after therapy(23). It is important
to take into account the serological study in search of
these markers during GBS, because the probable
association of antiganglioside antibodies (AGA) against
anti-CMV antibodies during this disease becomes
increasingly relevant (24).

newborns, of whom approximately 10% will develop
symptoms (17).

Multiple complications (1.7-5.2%) of

va r y i n g s e ve r i t y h ave b e e n d e s c r i b e d, w i t h

e expansion of the Zika virus in America and its
probable relationship with GBS

neurological origins such as encephalitis, meningitis,
and GBS is very common (17).
Since the late 1960s, the association between CMV and
GBS has been known. Studies have shown that around
12-13% of patients with GBS had a previous CMV
infection(18). It is currently considered the most common
viral infection associated with this syndrome, being
identi ed in up to 15% of patients by detection of
speci c IgM antibodies and in 62% of patients by DNA
detection (19). It is estimated that the risk of GBS after
CMV infection can reach 0.6-2.2 cases per 1,000 people
.

(20)

Likewise, it has been suggested that molecular mimicry
with neuronal structures in primary CMV infection is
more likely than in the course of virus reactivation, due
to lower antibody speci city and aﬃnity early after
infection(19). On the other hand, GBS occurs sporadically
in kidney transplant patients, in whom the use of oral
antiviral drugs in combination with immunoglobulins
and plasmapheresis reports relative success ( 2 1 ) ,
however, analytical studies and clinical trials are lacking.
regard.
In childhood, GBS after CMV infections is rarely reported
and if it does occur, it often begins with severe
symptoms and longer recovery times. However, the
sensory-motor axonal form of the syndrome after CMV
infection has a good outcome prognosis with prompt
and complete recovery in children (22).

The virus was rst isolated in the Zika forest of Uganda
in Africa around the 1950s, and reappeared in 2007,
with important reports of fever taking place on the
island of Yap, in the western Paci c (Micronesia) (25). Years
later, French Polynesia was rst aﬀected by ZIKV (26) and
although in recent years the risk of microcephaly and
other congenital brain anomalies were the main
complications associated with the virus (25) , during the
outbreak of October 2013 and April 2014, a study
reported that of 42 patients with GBS, 37 (88 %)
developed a viral syndrome compatible with ZIKV at a
median of six days before the development of
neurological symptoms. The characteristics and
evolution corresponded to the NAMA subtype of GBS
(27,28)
.
Likewise, in 2016, Colombia registered 68 patients with
GBS, of which 97% had clinical symptoms compatible
with ZIKV infection, nding both virus RNA and
anti avivirus antibodies in 40 and 43% of patients. It
was even suggested that GBS be reconsidered as a
parainfectious complication, instead of a postinfectious
one (28,29). However, we must take into account that this
probable relationship was suggested based on
descriptive studies where GBS cases were reported
during a Zika outbreak evaluating parameters such as
frequency and incidence, but there are no conclusive
studies in this regard, being necessary to carry out
analytical studies to determine the association
between this arbovirosis with diﬀerent neurological
alterations such as GBS(30).
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e Antibody-Dependent Enhancement Model
(ADE) of the Dengue virus and its relationship
with GBS

meningitis, and even GBS, most of which have been
reported mainly in children(37-39). Studies have shown
that up to 90% of patients who developed GBS may
have high IgG titers for EBV and anti-GM1 and GM3

The Dengue virus represents the most important

antibodies (40).

arbovirus that currently aﬀects humans, both in the
febrile syndrome and in the severe type, it can include

The presence of EBV infection in GBS is relatively rare,

neurological signs such as acute transverse myelitis,

with a related incidence rate of 0.36% and although the

acute disseminated encephalomyelitis, and GBS .

evolution in children is frequently complete, it seems

(31)

Although most reports do not describe demyelination

that this would not be the case in children under two

as a speci c complication (32,33), there are case series

years of age(41). FMS has been associated with primary

reports that relate it to GBS(31) and others that relate the

EBV infections, both in children and adults, where anti-

NASMA variant as a possible neurological complication

GQ1b antiganglioside antibodies were found in 90% of

by DENV(34).

FMS cases and positive serology for VCA and EBNA, as
well as the presence of the virus in plasma. which

Hemorrhagic fever and Dengue shock syndrome arise

suggests a late primary infection (42). However, it is

through immunopathological mechanisms following

important to properly interpret these types of events

sequential infection of an individual with these

because the presence of antibodies against EBNA

antigenically related heterologous serotypes. "Immune

would indicate an infection approximately three

potentiation" is believed to play an important role in
pathogenesis. Several antigenic determinants for
infection-enhancing antibodies have been found on
the envelope glycoprotein. Therefore, the same crossreacting antibodies from a previous infection could act
against antigenic determinants leading to
demyelination under an antibody-dependent
enhancement (ADE) model

. However, regarding

(32,35)

the nervous manifestations, there is great controversy
about whether the neurological signs associated with
DENV infection are due to direct infection in the
nervous tissue, or if they are the result of nerve
dysfunction associated with damage. or failures in
extraneural organs, as in the case of hepatic
encephalopathy, or the presence and constant

months earlier, making the participation of this virus in
GBS unlikely due to being an event that is too late.
A true association between the virus and the syndrome
should be determined by the presence of IgM
antibodies against VCA in the absence of EBNA
antibodies, which would reveal a very recent infection
and help elucidate the cause of the disease.
Va r i c e l l a Zo s t e r v i r u s ( V Z V ) b e l o n g s t o t h e
Herpesviridae family, which is known to have a tropism
for the peripheral nervous system. Neurological
complications are reported after infection by this virus.
Of these, encephalitis is the most common (1: 1,000)

circulation of systemic in ammatory mediators or

people (43) and GBS the least common (1: 15,000)

metabolites increased by the infection, which

people (44). Less than 50% of these cases have been

modulate neurological function.

reported in the literature and, when they occur, it is
almost always due to the reactivation of latent VZV in

To elucidate this, complete clinical and paraclinical

Herpes zoster (shingles)(43). Nevertheless, In Bangladesh,

analyzes and the use of complex imaging would be

the frequency of GBS preceded by primary infection by

required, however, these are almost never done(36).

VZV has been described. Between 2010 and 2016, of
536 patients, only 1.3% (seven patients) had

e epstein-Barr virus precedes GBS mainly in
children
The Epstein-Barr virus (EBV) can present neurological
manifestations that include encephalitis, aseptic
Pág. 589
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from the axonal form of GBS that predominates in this
countr y

(45)

. However, an alternative mode of

Post-exposure GBS to the in uenza virus and the
probable eﬀect of its vaccine

pathogenesis in PDIA, which is currently poorly
understood, has been suggested elsewhere(43).

Neurological manifestations are an important
complication of In uenza infection. A wide variety has
been repor ted, of which febrile seizures and

GBS usually occurs in the early stages of infection
by the human Immunode ciency Virus (HIV)

encephalopathy are the most common, with
approximately three-quarters of cases occurring in
children (53,54). A French study determined that of 73

Neurological involvement in HIV-infected patients is
common and involves the central and peripheral
nervous systems. It has been suggested that 30% of
these present neurological involvement as the rst

patients with GBS of unidenti ed cause, 13.7% had
serological evidence of In uenza A virus, while 5.5%
had In uenza B (55).
Likewise, one study found an increase in GBS two

manifestation of HIV infection and it is recognized as

months after infection associated with similar

the cause of death in 11% of them(46,47).

symptoms of In uenza or acute respiratory infection.
However, GBS has been reported sporadically in cases

In 1985, the association between GBS and HIV in a

of In uenza 2009 AH1N1(56). Likewise, in a Norwegian

patient with AIDS was described for the rst time. Three

study of 490 GBS cases during 2009-2012, 410 occurred

GBS patients were then described, at the onset of HIV

after October one, 2009, of which 46 new cases

infection, before AIDS . Currently, GBS in HIV-infected

occurred during the peak period of the in uenza

patients is considered to precede overt AIDS and

pandemic. This indicated that there was a signi cantly

(48)

evidence of immunosuppression (48,49). A study of 32 GBS
patients in Zimbabwe found that 16 (55%) had HIV
infection(50). Although some patients had AIDS and GBS,
it has been suggested that GBS occurs early in HIV
infection with high blood counts. CD4 lymphocytes (>

increased risk of GBS during and after pandemic
in uenza infection (57).
On the other hand, there are also reports of GBS after
exposure to the in uenza vaccine. In 1976, the United
States began a massive immunization program against

500) (48,49). In Tanzania, this association has been

the A/NJ/76 strain of In uenza H1N1, with 40 million

con rmed, with a prevalence of 30.5% (11 of 36

vaccines distributed, after which a total of 532 cases of

patients) of the virus in patients with GBS. GBS

post-vaccination GBS were reported (58). It has been

seropositive patients had a shorter duration of onset,

proposed that the viral compounds of the vaccine,

greater neurological involvement, and a higher

under certain conditions, could result in a structure that

mortality rate 45.5% (5/11) versus 16% (4/21) compared

mimics ganglioside epitopes and thereby explain

with seronegatives

molecular mimicry (56).

.

(50,51)

In recent years, the role of HIV has become so important
that some researchers refer to the need for patients
with symptoms of GBS, regardless of clinical history, to
be oﬀered an HIV test. Because the syndrome may be
the

rst sign that a patient is HIV positive (52) and

although GBS usually occurs mainly before the AIDS

Hepatitis viruses and GBS
There is evidence that hepatitis viruses, especially
hepatitis A as an antecedent to the development of
GBS, as for this virus, there is enough literature that
indicates it as a frequent complication, which would be
related mainly to cases arising in young adults between
21 and 34 years old

(59-62)

; it should be noted that no

phase, it should be considered that in advanced stages

report found that children were aﬀected after infection

concomitant infections with other viruses, especially

by this virus. Regarding hepatitis E (HEV), it is known

CMV, could develop the disease(46).

that it can cause extrahepatic manifestations.
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Several cases have been reported with HEV infections

Enterovirus D68 can cause a wide range of respiratory

associated with neurological disorders, including GBS,

disorders in children, from pharyngitis and bronchitis to

brachial neuritis, and polyradiculopathy. Interestingly,

more severe pneumonia and respiratory failure. Healthy

one-third of GBS patients show mild liver function
abnormalities with no obvious cause

. Some reports

adults can also become infected with Enterovirus D68

(63,64)

(EV D68), although it usually presents with a milder

have found an association of up to 5% of patients with
range of respiratory symptoms(68).
GBS who recently had an infection by (HEV) with high
levels of IgM anti-HE V antibodies, however,
antiganglioside antibodies were not detected

However, EV D68 is strongly associated, both in children

. Therefore, their association is unlikely. As for hepatitis

and adults, with acute accid myelitis. (MFA) (69) , which is

B and C viruses, it is known that the former has rarely

a complex syndrome characterized by the sudden

been implicated in acute polyneuropathies mediated

onset of weakness in one or more limbs or in the

by the immune system that are classi ed under the

respiratory and bulbar muscles as a result of lower

term GBS; These associations have represented

motor neuron damage (70). Some reports from Peru

(65)

approximately 1% of GBS cases, and their report is very
rare . As for the second, it should be examined in high-

indicated the implication of EV D68 in the development

(66)

of GBS, however, there is no evidence to support it as a

risk patients to prevent the silent progression of chronic
probable cause of the syndrome, a fact that was widely
hepatitis C and its potentially serious extrahepatic
manifestations, which in rare cases also includes GBS(67).

Enterovirus D68: a distinct cause of

accid

discussed by a study on the subject(71).

Human parvovirus b19 and heterogeneous

paralysis

evidence as antecedents to GBS

Enteroviruses (EVs) are a large group of viruses,

The last 10 years have witnessed an increase in cases of

including Coxsackieviruses, Echoviruses, Enteroviruses
(68-71)

, and Polioviruses. Humans are the only natural host.

GBS associated with human Parvovirus B19 (PVB19).
Data in the literature on the incidence of neurological

The infection is highly contagious by direct contact and
manifestations remain scattered, and heterogeneous,
then enters the CNS, although it cannot be determined
whether this occurs during secondary viremia or by
upward migration through peripheral nerves.

and epidemiological information cannot be accurately
extrapolated (72). However, there are neuropathies very

Asymptomatic and minor infections are more frequent

similar to GBS and its associated variants (PVB19), more

than the paralytic forms, with a ratio ≥ 60:1, being the

frequently in children after developing erythema

main source of spread of the disease(68).

infectiosum ( fth disease).
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Symptoms include muscle weakness of the lower

The role of some viruses in the development of GBS is

extremities with mild sensory disturbances, are exia in

increasingly evident. Such is the case of CMV, whose

some cases, and others with myelinated and nonmyelinated axonal degeneration, compatible with
acute motor sensory neuropathy (73).

relationship has been known since the 1960s. Such is
the evidence that supports it that analytical design
studies have been able to calculate the risks of suﬀering

FMS has been reported in some pediatric cases with
facial diplegia, and abnormal demyelination with

from GBS against infection by this virus (20). Likewise,

alterations in motor and sensory nerve conduction.

some studies have managed to relate it to the presence

However, without antiganglioside antibodies, which

of antiganglioside antibodies (24). In the same way, the

would make us doubt a molecular mimicry behind this
event

. An atypical SMF called anti-GQ1b syndrome

(74)

Zika virus during 2013 was presented as an important

with unilateral acute paralysis of the third cranial nerve

cause of GBS and although observational studies

has even been reported (75). However, in none of these

supported this fact, there could be a selection bias in

cases was GBS speci cally mentioned.

DISCUSSION

the sense that all the evidence regarding these cases
arose during the development of a Zika virus outbreak.

GBS is an in ammatory disease of the peripheral
nervous system and is the most common cause of acute
accid paralysis. In Peru, between 2012 and 2017, 955
cases of GBS were reported, with a higher frequency in

When analyzing the role of the Varicella Zoster virus in
the development of the disease, it does not seem to be

men and the population aged 20 to 59 years. The

so relevant. In a 2019 study, of all the infectious agents

national incidence of GBS per 100,000 inhabitants was

reported in patients diagnosed with GBS, antibodies

0.91 in 2017, being higher in older adults and men.
Likewise, the overall fatality rate was 3.5%, which was

against this virus were found in only one % of them (78).

higher in those older than 60 years. However, in 2018

This low frequency would be attributed to the fact that

and 2019 the number of cases experienced a dramatic

the number of chickenpox cases has decreased due to

increase, mainly on the north coast of the country,
leading to suspicion of a post-infectious origin, as

the vaccine and, although it occurs sporadically, in

happened in the Zika virus epidemics in French

some cases of GBS, it is important to consider the role of

Polynesia in 2013 and in Latin America and the

this virus as a possible etiological agent (79).

Caribbean in 2015 - 2016 where the number of GBS
cases also followed this pattern (76).
The role of this virus in GBS would be explained by the
In recent years there have been major outbreaks of the

fact that despite lacking an envelope, it has a recently

disease and in this context, the search for an etiological

described lipid cover

agent becomes more and more justi able because,
despite its autoimmune nature, the seasonal patterns,

(81)

, which could present

gangliosides responsible for molecular mimicry. Other

the number of cases, and the previous clinical

viruses mentioned as antecedents of GBS, which have

characteristics suggest the presence of an infectious

been reported in sporadic cases, are the rubella virus

agent involved. Regarding this, in 2019 some reports in

and the recent SARS-CoV-2, of which, although an

Peru indicated that Enterovirus D68 would have some
relationship with GBS. However, the latter was widely
disputed(77).

important role in neurological damage has been
reported, it is not yet known if participate in GBS (82).
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nding articles that jointly report

appropriate due to the above. Serological studies

neuropathies such as GBS and infectious agents in situ

focused on the search for etiological agents of GBS are

The fact of

(83)

; motivates questioning the role played by the latter in

certain pathologies. In this sense, it is known that

very few, one of the latest on this topic reports in uenza
A and B, hepatitis A virus, DENV, CMV, and EBV as
important antecedents of GBS after Campylobacter spp

neuropathies are generally divided into post-infectious

.

(78)

and para-infectious categories. The rst is caused by
autoimmune reactions to the infectious agent, which

CONCLUSION

cross-react with neural antigens from Schwann

Given the available scienti c evidence, the role played

cells/myelin or axons in the peripheral nerve. As occurs

by viruses in the etiology of GBS is undeniable.

in GBS, in which polyneuropathy usually develops

Although Campylobacter spp. It is still the main agent
involved in this syndrome, many viruses such as

several weeks after infection.

In uenza A, CMV, Zika, among others, are also involved
in its origin. Apparently, an important and necessary
As for the second, parainfectious neuropathies usually
develop during or shortly after an acute infection.

condition for these infectious agents to produce GBS
would be the presence of an envelope, which would

These develop as a direct consequence of infection or as

favor molecular mimicry, mainly with antiganglioside

an unusual hyperimmune response. Infectious agents

antibodies that would subsequently trigger the

that cause neuropathies by this mechanism include

disease.

Borrelia species, Brucella, Clostridium botulinum, and
West Nile virus, which can cause polio-like illness

. In

(84)

this regard, according to the pathophysiology of the

Therefore, the role of naked viruses in the production of
GBS would be unlikely. The post-infectious nature of the
disease should be considered, and not guide the search

development of GBS described above (Figure 2), there is
no evidence that this syndrome is parainfectious,

for etiological agents in situ, which for many years
would have contributed to reporting the cause of this

therefore, any isolation of infectious agent concomitant

syndrome as idiopathic as there was no reportable

with the development of the syndrome should not be

nding. A suitable tool for this purpose would be the

considered as a probable causal agent (77).

serological study since the presence of antibodies
would reveal infectious events that occurred previously.

The most appropriate studies to investigate the role of

Finally, it is important to recognize viruses as the
causative agents of GBS, especially when outbreaks of

viruses in GBS should be oriented to the search for
antibodies, due to the post-infectious nature of the

this disease occur, which, due to the demographic and
clinical pattern presented by patients, make it necessary

disease. Studies that look for a virus in situ would

to think that an infectious agent is circulating. A fact that

represent recognizing its parainfectious nature;

should reorient containment measures against this

however, this approach is far from being the most

disease. Available at.
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